Clinical trial

Immediate Release Versus Slow Release Carvedilol in Heart Failure

NCT03209180

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2016-10-27

PhasePHASE4

Study timeline

Study start (actual)2016-10-27Date precision: day

Registry last updated2017-07-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failure With Reduced Ejection Fractionunresolved

Interventions

CarVeDilol-SR (Slow Release)DRUG

Carvedilol IR (Immediate Release)DRUG

Sponsors & collaborators

Seoul National University Bundang Hospitallead sponsor

Chong Kun Dang Pharmaceutical Corp.collaborator

Mapped research locations

SeoulSouth Korea3

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03209180 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.